digital health vendors glp-1 medication-assisted weight loss programs The Impact of Agonists on the MedTech Sector: Articulating a continued value proposition for devices Alarming rise in weight loss

[DOI] [PubMed] [Google Scholar] 35.Hisadome K., Reimann F., Gribble F.M., Trapp S

Ongoing low-dose maintenance (experimental) Continuous dosing approach: Dose: 1-2mg daily OR 3-5mg 2-3x weekly Duration: Ongoing (not cycled) Goal: Maintain constant telomerase activation Status: Experimental, not from research protocols Rationale: Telomerase needs continuous activation to maintain telomere length Cyclic dosing may allow regression between cycles Low-dose continuous might provide stable benefits Similar to maintenance protocols for other peptides Continuous dosing options: Advantages of continuous: No "off" periods where benefits regress Potentially stronger cumulative anti-aging More like natural physiologic regulation Easier to stack with other peptides Disadvantages: Much higher annual cost ($1,800-3,600 vs $300-600) No long-term safety data Uncertain if better than cyclic approach Storage challenges (more reconstitution) Deviates from proven protocols Current recommendation: Stick with proven 10-day cycles for most users Consider continuous only if cyclic approach inadequate Start with standard protocol first Assess your individual response Consult with peptide-knowledgeable physician Use our peptide cycle planning guide to design your Epithalon protocol

doi: 10.1677/JOE-09-0132

And at a fraction of the standard dose

Shima Hadidchi MD Family Practice, we are committed to helping our patients achieve optimal health and well-being, including support for weight management and chronic disease prevention

Concurrent iron-deficiency anemia and folic acid deficiency may result in a blunted or impeded response to cyanocobalamin therapy.1